Home page
AI is hyped, useless
AI cannot predict drugs or superbugs
(Fig.1) Overhyped AI's prediction rate of proteins is very bad = only 2%

The 7th, 2nd-last paragraphs of this hyped news (7/24/2025) say
"a well-known cancer target, NY-ESO-1, which is found in a wide range of cancers. The team succeeded in designing a minibinder that bound tightly to the NY-ESO-1 pMHC molecules. When the designed protein was inserted into T cells,.. which effectively guided the T cells, to kill cancer cells in laboratory experiments (= Not inside bodies, so still useless )."
"expects that it will (= still useless ) take up to five years before the new method is ready for initial clinical trials in humans."
↑ So this research tried to make AI, Alphafold design minibinder proteins (= with very low success rate of less than 2%, this-p.8-1st-paragraph, which is useless, too bad to predict side effects ) binding to cancer antigen to stimulate T cell to kill cancers in vitro (= Not inside animals or bodies ).
↑ This CAR-T cell therapy for solid tumors did Not succeed despite many attempts, because T-cells are often blocked from reaching cancer cells inside bodies ( this-3.car T-cell theory in solid tumors, this-p.1-left-last-paragraph ).
This-abstract says -- Deadend T-cell therapy
"Despite early signs of clinical efficacy, CAR-T cells have repeatedly failed to achieve curative responses in solid cancers."
↑ This research paper ↓
p.2-last-paragraph says -- AI low success rate
"Among various de novo protein design approaches, RFdiffusion (= AI trained on experimental protein structure in PDB, this-p.68-4.1, Not quantum mechanics ) is considered one of the most
promising tools due to an impressive average of ~10% success rate of designed binders (= too bad and low AI success rate )"
p.3 says -- AI's design of binder to cancers
"In our work, we focused on
designing binders that specifically target the pMHC formed by MHC-I, presenting the cancer-associated
NY-ESO-1 peptide"
"Following backbone generation
through RFdiffusion denoising trajectories, we designed sequences using ProteinMPNN.
The resulting designs were filtered based on AF2 (= Alphafold 2 ) initial guess"
p.5-1st-paragraph says -- AI wrong prediction
"there is still a high rate of false positives, where
predicted binders fail during experimental testing" ← AI prediction of protein structures is bad.
p.6-upper says -- CAR-T-cell
"synthetic genes encoding all 44 miBd
designs targeting SLLMWITQC/HLA-A*02:01 (= another cancer antigen ) were cloned into a lentiviral CAR vector for
expression on the cell surface "
"From this library, we identified one candidate (NY1-B04)," ← So only one binder-protein out of 44 candidates predicted by AI bound to the target peptide. ← AI success rate was very bad = only 1/44
p.8-1st-paragraph-lower says -- Only 2% AI success rate
"We selected 95 miBds for in vitro testing,
constituting a success rate of ~2%" ← Also in design of binders targeting other peptides, the AI success rate was very bad = only 2%.
↑ As shown here, today's AI's success rates of actual proteins' structures were very bad ~2%, because the experimental (static) protein structures in PDB on which AI, Alphafold are trained are different from actual protein structures inside bodies or cells.
↑ To cure cancers, we should stop relying on T cell's immunity that is useless, often blocked by cancers inside bodies.
And we should directly measure atomic structures of cancer cells (= which direct observation of atoms and cells is impossible in today's X-ray and cryo-EM ) by practical multi-probe atomic force microscopes that can design and directly create molecules or effective drugs binding only to cancer cells to prevent them proliferating.
↑ Only atomic force microscopes (with useful multiple probe tips) can directly observe and know the precise atomic structures over (cancer, HIV, auto-immune) cells and tissues, combined with artificial manipulation or chemical bond breaking ( this-p.17 ) separating attached molecules from the target cells gradually. → Designing and directly creating drug molecules binding only to the target sick (cancer, HIV autoimmune.. ) cells and preventing them from proliferating as effective treatment.
↑ Development of this useful multi-probe atomic force microscopes has been hampered by the current impractical quantum mechanical atomic model.

Feel free to link to this site.